Clinical trials of xenotransplantation: Waiver of the right to withdraw from a clinical trial should be required

Journal of Law, Medicine and Ethics

Volumn 35, Issue 2, 2007, Pages 265-272

  Spillman, Monique A ^a   Sade, Robert M ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b Department of Cardiothoracic Surgery ^*

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHIMERA; CLINICAL TRIAL; ETHICS; HUMAN; LEGAL ASPECT; LIVING WILL; PATIENT; UNITED STATES; XENOGRAFT;

ADVANCE DIRECTIVES; CHIMERA; CLINICAL TRIALS; HUMANS; PATIENT DROPOUTS; TRANSPLANTATION, HETEROLOGOUS; UNITED STATES;

EID: 34249093841     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2007.00135.x     Document Type: Article

References (59)

1. United States Public Health Service, Department of Health and Human Services, Guideline on Infectious Disease Issues in Xenotransplantation, January 19, 2001, at 15 [hereinafter cited as Guideline].
2. C. Hammer Comments on Ethics in Human Xenotransplantation in D. K. C. Cooper, E. Kemp, J. L. Platt, and D. J. G. White, eds., Xenotransplantation: The Transplantation of Organs and Tissues between Species (Berlin : Springer-Verlag 1997 766-773, at 769.
3. J.-Y. Deschamps, F. A. Roux, P. Sai, and E. Gouin History of Xenotransplantation Xenotransplantation 12 (2005 91-109, at 96.
4. Id., at 93, Table 4.
5. R. Malouin Surgeons' Quest for Life: The History and the Future of Xenotransplantation Perspectives in Biology and Medicine 37, no. 3 (1994 416-428, at 421-423.
6. Id.
7. See Deschamps et al., supra note 3, at 98.
8. F. Bach and H. Fineberg Call for Moratorium on Xenotransplants Nature 391 (1998 326.
9. L. E. Chapman Zoonosis as a Risk to the Xenograft Recipient and to Society: Theoretical Issues in J Platt, ed., Xenotransplantation (Washington, D.C. : ASM Press 2001 207-216, at 208.
10. R. A. Weiss Retroviruses and Xenotransplantation in J Platt, ed., Xenotransplantation (Washington, D.C. : ASM Press 2001 239-250, at 243.
11. W. B. Karesh and R. A. Cook The Human-Animal Link Foreign Affairs 84, no. 4 (2005 38-50, at 41.
12. Id.
13. P. J. Matthews Zoonotic Agents: Swine to Humans in J Platt, ed., Xenotransplantation (Washington, D.C. : ASM Press 2001 217-238, at 235.
14. Id.
15. Guideline, supra note 1, at 14.
16. Committee on Xenograft Transplantation : Ethical Issues and Public Policy, Division of Health Sciences Policy, Division of Health Care Services, Institute of Medicine, Xenotransplantation: Science, Ethics, and Public Policy (Washington, D.C. : National Academy Press 1996) at 92.
17. J. A. Fishman Prevention of Infection in Xenotransplantation in J Platt, ed., Xenotransplantation (Washington, D.C. : ASM Press 2001 261 290, at 272.
18. Id., at 276.
19. C. Patience, Y. Takeuchi, and R. A. Weiss Infection of Human Cells by an Endogenous Retrovirus of Pigs Nature Medicine 3, no. 3 (1997 282 286.
20. See Deschamps et al., supra note 3, at 103.
21. R. M. Baertschiger and L. H. Buhler Xenotransplantation Literature Update November-December, 2004 Xenotransplantation 12 (2005 156-160, at 157.
22. See Deschamps et al., supra note 3, at 103.
23. Center for Biologics Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services, Guidance for Industry: Precautionary Measures to Reduce the Possible Risk of Transmission of Zoonoses by Blood and Blood Products from Xenotransplantation Product Recipients and Their Contacts, December, 1999.
24. Id., at 4.
25. Guideline, supra note 1, at 20-22, 35-38.
26. Id., at 20.
27. Center for Biologics Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services, Guidance for Industry: Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans: FINAL GUIDANCE, April, 2003, i-60, at 48 [herein cited as Guidance for Industry].
28. Guideline, supra note 1, at 21.
29. Id., at 35.
30. Id., at 36.
31. Id.
32. Id., at 37.
33. Id.
34. Guidance for Industry, supra note 26, at 49.
35. Guideline, supra note 1, at 21.
36. Id.
37. Guidance for Industry, supra note 26, at 56.
38. Guideline, supra note 1, at 42.
39. A. L. Caplan Is Xenografting Morally Wrong in A. L. Caplan and D. H. Coelho, eds., The Ethics of Organ Transplants (Amherst, New York : Prometheus Books 1998 121 132, at 131.
40. U.S. National Commission for the Protection of Human Subjects of Biological and Behavioral Research, The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research, Department of Health, Education, and Welfare (DHEW), Publication No. (OS) 78-0012, Appendix I, DHEW Publication No. (OS) 78-0013, Appendix II, DHEW Publication No. (OS) 78-0014, U.S. Government Printing Offce, Washington, D.C., 1978.
41. World Medical Association World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects JAMA 284, no. 23 (2000 3043 5.
42. Guideline, supra note 1, at 19-20.
43. M. Sykes, A. d'Apice, and M. Sandrin on behalf of the IXA Ethics Committee, "Position Paper of the Ethics Committee of the International Xenotransplantation Association Transplantation 78, no. 8 (2004 1101-1107, at 1103.
44. P. S. Florencio and E. D. Ramanathan Legal Enforcement of Xenotransplantation Public Health Safeguards Journal of Law, Medicine & Ethics 32, no. 1 (2004 117-123, at 118.
45. Id.
46. D. K. C. Cooper and R. P. Lanza, eds., XENO: The Promise of Transplanting Animal Organs into Humans (New York : Oxford University Press 2000 at 217.
47. See Florencio, supra note 43, at 119.
48. United States Supreme Court O'Connor v. Donaldson, 422 U.S. 563 (1975).
49. See Florencio and Ramanathan, supra note 46.
50. Id.
51. Id.
52. Id., at 120.
53. R. Spellecy Reviving Ulysses Contracts Kennedy Institute of Ethics Journal 13, no. 4 (2003 373-392, at 375.
54. Id., at 375; personal communication with author, January 10, 2006.
55. Id., at 373.
56. See Sykes et al., supra note 42, at 1103.
57. See Spellecy, supra note 52, at 374.
58. Id., at 375.
59. J. F. Battey, National Institutes of Health: Support for Human Embryonic Stem Cell Research, paper presented at the Forum for Medical Affairs, Dallas, Texas, November, 6, 2005.